Similar Articles

Progressive pulmonary fibrosis in patients with connective tissue disease-associated interstitial lung disease: An explorative study

Jakob Höppner, Maximilian Wollsching-Strobel, Falk Schumacher, Wolfram Windisch, Melanie Berger

DOI: 10.46497/ArchRheumatol.2024.10105

Issue: Volume 39 - Issue 1 - March 2024
338 375

Left ventricular systolic function assessed by standard and advanced echocardiographic techniques in patients with systemic lupus erythematosus: A systemic review and meta-analysis

Maka Gegenava, Zviad Kirtava, William KF Kong, Tea Gegenava

DOI: 10.46497/ArchRheumatol.2024.10131

Issue: Volume 39 - Issue 1 - March 2024
284 273

Early effectiveness and safety analysis of belimumab in addition to standard treatment in patients with systemic lupus erythematosus

Lingyan He, Mingming Yan, Rui Wen, Jiali Li

DOI: 10.46497/ArchRheumatol.2024.9977

Issue: Volume 39 - Issue 2 - June 2024
26 42

Predictive risk factors for one-year mortality in idiopathic inflammatory myopathy patients with interstitial lung disease: A retrospective, single-center cohort study

Minna Jiang, Xiaohong Wen, Sisi Xia, Yiqun Guo, Yu Bai

DOI: 10.46497/ArchRheumatol.2024.10418

Issue: Volume 39 - Issue 2 - June 2024
31 54